Skip to main content

Table 4 Distribution of AKI incidence by baseline eGFR and AKI stage

From: Risk of acute kidney injury and survival in patients treated with Metformin: an observational cohort study

  eGFR (ml/min/1.732)
AKI Stage <30 30-60 >60
  n Person time (years) Incidence rate (per 1000 person-years) n Person time (years) Incidence rate (per 1000 person-years) n Person time (years) Incidence rate (per 1000 person-years)
1 439 1829 240 2187 31,350 70 1717 84,163 20
2 16 1829 8.7 43 31,350 1.3 81 84,163 1.0
3 167 1829 91 142 31,350 4.5 129 84,163 1.5